CORRECTED-Cipla cuts generic Nexavar price by 75 pct in India

MUMBAI, May 3 (Reuters) - Indian drugmaker Cipla
has cut the price of the generic version of Bayer's
renal cancer drug Nexavar by 75 percent and will sell it at
6,840 rupees ($130) for a monthly dose, its chairman said on
Thursday.

service king collision